Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:2) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 243 | pmol/sample |
| - | PE(38:2) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 252 | pmol/sample |
| - | PE(38:2) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 257 | pmol/sample |
| - | PE(38:2) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 149 | pmol/sample |
| - | PE(38:2) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 124 | pmol/sample |
| - | PE(38:2) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 133 | pmol/sample |
| - | PE(38:2) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 139 | pmol/sample |
| - | PE(38:2) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 188 | pmol/sample |
| - | PE(38:2) | C | 0.0 | BCD100427B001 | 349 | pmol/sample |
| - | PE(38:2) | C | 0.5 | BCD100427B003 | 177 | pmol/sample |
| - | PE(38:2) | C | 1.0 | BCD100427B007 | 328 | pmol/sample |
| - | PE(38:2) | C | 2.0 | BCD100427B011 | 141 | pmol/sample |
| - | PE(38:2) | C | 4.0 | BCD100427B015 | 151 | pmol/sample |
| - | PE(38:2) | C | 8.0 | BCD100427B019 | 130 | pmol/sample |
| - | PE(38:2) | C | 12.0 | BCD100427B023 | 87.9 | pmol/sample |
| - | PE(38:2) | C | 24.0 | BCD100427B027 | 146 | pmol/sample |
| - | PE(38:2) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 160 | pmol/sample |
| - | PE(38:2) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 156 | pmol/sample |
| - | PE(38:2) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 136 | pmol/sample |
| - | PE(38:2) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 130 | pmol/sample |
| - | PE(38:2) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 127 | pmol/sample |
| - | PE(38:2) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 104 | pmol/sample |
| - | PE(38:2) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 238 | pmol/sample |
| - | PE(38:2) | 25OH-Chol | 0.5 | BCD100427B004 | 332 | pmol/sample |
| - | PE(38:2) | 25OH-Chol | 1.0 | BCD100427B008 | 138 | pmol/sample |
| - | PE(38:2) | 25OH-Chol | 2.0 | BCD100427B012 | 288 | pmol/sample |
| - | PE(38:2) | 25OH-Chol | 4.0 | BCD100427B016 | 177 | pmol/sample |
| - | PE(38:2) | 25OH-Chol | 8.0 | BCD100427B020 | 135 | pmol/sample |
| - | PE(38:2) | 25OH-Chol | 12.0 | BCD100427B024 | 130 | pmol/sample |
| - | PE(38:2) | 25OH-Chol | 24.0 | BCD100427B028 | 126 | pmol/sample |